BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bargnoux A, Beaufils O, Oguike M, Lopasso A, Dupuy A, Sebbane M, Badiou S, Fesler P, Cristol J. Point-of-care creatinine testing in patients receiving contrast-enhanced computed tomography scan. Clinica Chimica Acta 2018;478:111-3. [DOI: 10.1016/j.cca.2017.12.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 El-Khoury JM, Hoenig MP, Jones GRD, Lamb EJ, Parikh CR, Tolan NV, Wilson FP. AACC Guidance Document on Laboratory Investigation of Acute Kidney Injury. J Appl Lab Med 2021:jfab020. [PMID: 33973621 DOI: 10.1093/jalm/jfab020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bargnoux AS, Kuster N, Sutra T, Laroche L, Rodriguez A, Morena M, Chenine L, Chalabi L, Dupuy AM, Badiou S, Cristol JP. Evaluation of a new point-of-care testing for creatinine and urea measurement. Scand J Clin Lab Invest 2021;81:290-7. [PMID: 33908840 DOI: 10.1080/00365513.2021.1914344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Shinkins B, Harris M, Lewington A, Abraham S, Snaith B. Kidney function testing prior to contrast-enhanced CT: a comparative cost analysis of a personalised risk-stratified pathway versus a test all approach. Clin Radiol 2021;76:202-12. [PMID: 33109348 DOI: 10.1016/j.crad.2020.09.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Mathur N, Lu ZX, MacKay L, Lau T, Kuganesan A, Lau KK. Is point of care renal function testing reliable screening pre-IV contrast administration? Emerg Radiol 2021;28:77-82. [PMID: 32725604 DOI: 10.1007/s10140-020-01829-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Nichols JH, Alter D, Chen Y, Isbell TS, Jacobs E, Moore N, Shajani-yi Z. AACC Guidance Document on Management of Point-of-Care Testing. The Journal of Applied Laboratory Medicine 2020;5:762-87. [DOI: 10.1093/jalm/jfaa059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
6 Broughton-Neiswanger LE, Rivera-Velez SM, Suarez MA, Slovak JE, Piñeyro PE, Hwang JK, Villarino NF. Urinary chemical fingerprint left behind by repeated NSAID administration: Discovery of putative biomarkers using artificial intelligence. PLoS One 2020;15:e0228989. [PMID: 32053695 DOI: 10.1371/journal.pone.0228989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 van der Heijden C, Roosens L, Cluckers H, Van Craenenbroeck AH, Peeters B. Analytical and clinical performance of three hand-held point-of-care creatinine analyzers for renal function measurements prior to contrast-enhanced imaging. Clinica Chimica Acta 2019;497:13-9. [DOI: 10.1016/j.cca.2019.06.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
8 Snaith B, Harris MA, Shinkins B, Messenger M, Lewington A, Jordaan M, Spencer N. Point of care creatinine testing in diagnostic imaging: A feasibility study within the outpatient computed tomography setting. Eur J Radiol 2019;112:82-7. [PMID: 30777224 DOI: 10.1016/j.ejrad.2019.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]